Hemoglobin-based oxygen carriers: compassionate use and compassionate clinical trials.
Weiskopf
Richard B
RB
D000740:Anemia / Q000097:blood / Q000401:mortality / Q000628:therapy*; D001802:Blood Substitutes / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D057176:Compassionate Use Trials; D000075202:Contraindications; D017277:Drug Approval; D019317:Evidence-Based Medicine; D006454:Hemoglobins / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome; D016312:Treatment Refusal; D014481:United States; D014486:United States Food and Drug Administration
D001802:Blood Substitutes; D006454:Hemoglobins; C096798:HBOC 201